Navigation Links
Optec 6500P Vision Tester

ProductsOptec 6500P Vision Tester
Company Stereo Optical Company
Item Optec 6500P Vision Tester
Features 
  • New Unsurpassed Homogenous Illumination
  • Background Luminance Complies with International Standards
  • All Light Levels Microprocessor Controlled and Continually Calibrated
  • Binocular Glare Testing
  • Target Illumination comes standard with 3.0 cd/m2 for night testing, and 85 cd/m2 for day testing, or may be customized* to specific needs with a value range of 1.0 cd/m2 to 125 cd/m2
  • Glare luminance at distance comes standard with 1 Lux for night glare testing and 10 Lux for day glare testing, or may be customized* to specific needs with a value range of 1 Lux to 50 Lux
  • Contrast Sensitivity test to evaluate the patient's overall functional vision. Choose from either Sine Wave (F.A.C.T.) or Letter (C.A.T.)
  • Potential Acuity for a quick assessment of macular function
  • Select a standard test package, or customize* to specific testing needs by choosing up to 12 slides from the library of over testing slides 150
Description Assess Functional Vision, Quality of Vision and Contrast Sensitivity. The Optec 6500 controls both target illumination and glare luminance levels for accurate and repeatable testing results. Day/Night testing with/without glare and background luminance Comply with International Standards and all ANSI standards. All Light Levels Microprocessor Controlled and Continually Calibrated. The Optec 6500 Vision Tester includes EyeView Functional Vision Analysis Software which produces images of your patients real world vision and tracks the surgical outcomes of all eye surgery.
Info Stereo Optical Company
Customer Service: (773) 777-2869
Web site: http://www.stereooptical.com

Related medicine products :

1. Optec 3500 Vision Tester
2. Optec Vision Tester
3. Copeland Optec® 360 Retinoscope
4. Optec 5000 & 500P Vision Tester
5. Optec 5500 & 5500P Vision Tester
6. Optec 6500P
7. Optec 500
8. Optec 1000 Vision Tester
9. Vision Monitor Visual electrophysiology
10. VisionBlue
11. PVA, The Personal Vision Assistant
The Omni-Flex System provides the capability to change frame arms in the middle of surgery while retaining exposure with tension on the incision. The system is also strong enough to be stable for lar
...actor System represents the most widely accepted "...array of retraction components provides numerous s...lti-directional exposure of the surgical field. In...pecific procedures: IMA Kit / Bariatric Kit / Spin...
...he Alexis Wound Retractor provides circumferential...ination. For open surgery, the Alexis Retractor pr...ion size. For laparoscopic surgery, the Alexis Ret...protection when an organ or specimen requires remo...
Pipetman Concept is a revolutionary motorized electronic pipette. Conceived with simplicity and flexibility in mind, Pipetman Concept features exclusive multifunction characteristics and a direct pip
Medicine Products:
(Date:10/7/2008)...ty of Utah researchers have developed a magnetic r...and quantifying injury to the wall of the heart,s ...dure to treat atrial fibrillation. The results of ... of the Journal of the American College of Cardio...mia, or abnormal heart rhythm, that involves the h...
(Date:10/7/2008)...Newswire-USNewswire/ -- The Catholic Health,Associ... with Catholic,Health Initiatives (CHI), Denver; C... Health, Novi, MI -- is launching a ministry-wide ...nge., Through receipt of a $20,000 grant from the...t (NRPE) and the Catholic Coalition on,Climate Cha...
(Date:10/7/2008)...PRNewswire-FirstCall/ -- Majesco Entertainment,Com...ideo games for the mass,market, today announced th...ne gold and is scheduled to ship on October 21st f...ntegrate a celebrity fitness trainer --- Jillian,M...e popular television,series "The Biggest Loser" --...
(Date:10/7/2008)...ewswire/ -- Cleveland Medical Devices Inc.,(CleveM... NIH SBIR,FastTrack funding from the National Inst... to augment stimulator programming in deep brain,s...e (PD). CleveMed is,collaborating with clinicians ...Cleveland Clinic Foundation, a world renowned, pio...
Breaking Medicine News(10 mins):Health News:Novel imaging approach may assist in predicting success of treatment for atrial fibrillation 2Health News:Catholic Health Organizations Launch Ministry-Wide Effort to Raise Awareness About Global Climate Change 2Health News:Majesco Entertainment and Interactive Game Group Announce 'Jillian Michaels' Fitness Ultimatum 2009' Ships to Stores October 21st 2Health News:Majesco Entertainment and Interactive Game Group Announce 'Jillian Michaels' Fitness Ultimatum 2009' Ships to Stores October 21st 3Health News:CleveMed Receives $1.23 Million in NIH Funding to Develop a System to Augment Deep Brain Stimulation Programming in Parkinson's Disease 2
...ers at the University of Michigan C.S. Mott Childr...are at an increased// risk for influenza-related c...e flu, even when they visit their doctor during fl... Archives of Pediatric and Adolescent Medicine, th...
...national team of researchers is developing a new g...between donors and recipients//. The Bloodchip giv...sts. The current tests look for blood types while ...es”. A spokeswoman for the National Blood Service...
...ican Physical Therapy Association (APTA) has said ... part of workplace injuries. It is a repetitive-st...of the popular BlackBerry devices. "The use of PD... longer limited to the eight hours spent in the wo...
...ionel Richie was so fearful over his daughter Nico...r to the doctors personally and find out the probl...cared for his daughter's health and wanted to know...der. He says: "Believe me, I've checked it out t...
Other Medicine News:Health News:Few Medicaid Kids with Asthma Get Recommended Flu Shot 2Health News:Few Medicaid Kids with Asthma Get Recommended Flu Shot 3Health News:Novel genetic blood test 2
(Date:10/6/2008)...rate to Improve Patient Safety, WASHINGTON, Oct. ...of,Cardiology in collaboration with the American C...Association today released consensus guidelines,ou...of ulcers and,gastrointestinal (GI) bleeding among...gs (NSAIDs) along with antiplatelet agents., Gast...
(Date:10/6/2008)... Therapy is More Likely to Induce Steroid-Free R...d Immunomodulator, Azathioprin...sented for the first time,from the Phase 3b Study ...dulators and Biologic Therapy (SONIC) may provide ... with moderate to severe Crohn,s disease.,Accordin...
(Date:10/6/2008)...severe patients achieved endoscopic,response and m...at Week 10,in data from a 54-week open-label study...logy (ACG) Annual Scientific Meeting, ORLANDO, Fl...a from a,large, prospective study investigating en...a biologic compound. The data presented at the Ame...
(Date:10/6/2008)... Weeks of Radiation Therapy -, Event: Watch Single...day, October 22, 2008, 3 - 4 p.m. by visiting ...a., Oct. 6 / Questions raced through ...t cancer in May. Would she have the,tumor removed ...therapy?, , To view the Multimedia News Release,...
Breaking Medicine Technology:Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Aberrations in region of chromosome 1q21 1 associated with broad range of disorders in children 4819 1Aberrations in region of chromosome 1q21 1 associated with broad range of disorders in children 4819 2Aberrations in region of chromosome 1q21 1 associated with broad range of disorders in children 4819 3How do race genetics and health care disparities affect spread of HIV 3F 4816 1Eatn Park to Thank Guests for Their Support of the Chains Decision to Go Smoke Free 26272 19 11s Health Effects Lingered for Years 26268 19 11s Health Effects Lingered for Years 26268 29 11s Health Effects Lingered for Years 26268 3
...(BUSINESS WIRE)--May 25, 2007 - ARIAD,Pharmaceutic...ical,investigators from leading cancer centers wil...g trials of the Company,s novel mTOR,inhibitor, AP...ty,of Clinical Oncology (ASCO) in Chicago, Illinoi...he Phase 2 trial of single-agent,AP23573 in patien...
...(BUSINESS WIRE)--May 24, 2007 - A new analysis,has...igned in ways,that inadvertently omit women and Af...niversity School of Medicine,researcher who led th...tists that strict study eligibility criteria can h...ng data from a pool of 100,000 alcohol treatment,p...
Other Medicine Technology:Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 2Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 3Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 4Limiting Eligibility for Medical Studies Can Omit Women,African-Americans, Stanford Study Finds 2Limiting Eligibility for Medical Studies Can Omit Women,African-Americans, Stanford Study Finds 3